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Work at high altitude in shifts exposes humans to a new form of chronic intermittent hypoxia, with still unknown health
consequences. We have established a rat model resembling this situation, which develops a milder form of right ventricular
hypertrophy and pulmonary artery remodelling compared to continuous chronic exposure. We aimed to compare the alterations
in pulmonary artery nitric oxide (NO) availability induced by these forms of hypoxia and the mechanisms implicated. Rats were
exposed for 46 days to normoxia or hypobaric hypoxia, either continuous (CH) or intermittent (2 day shifts, CIH2x2), and
assessed: NO and superoxide anion availability (fluorescent indicators and confocal microscopy); expression of phosphorylated
endothelial NO synthase (eNOS), NADPH-oxidase (p22phox), and 3-nitrotyrosine (western blotting); and NADPH-oxidase
location (immunohistochemistry). Compared to normoxia, (1) NO availability was reduced and superoxide anion was increased in
both hypoxic groups, with a larger effect in CH, (2) eNOS expression was only reduced in CH, (3) NADPH-oxidase was similarly
increased in both hypoxic groups, and (4) 3-nitrotyrosinewas increased to a larger extent inCH. In conclusion, intermittent hypoxia
reduces NO availability through superoxide anion destruction, without reducing its synthesis, while continuous hypoxia affects
both, producing larger nitrosative damage which could be related to the more severe cardiovascular alterations.
1. Introduction
Exposure to hypoxia, in either chronic or intermittent
conditions, is associated with cardiovascular alterations.
Hypoxia-related diseases are well characterized in people
living at high altitude (chronic hypoxia, CH) [1] and in
obstructive sleep apnea (OSA), where hypoxic conditions
are maintained intermittently for brief periods [2]. Another
mode of intermittent hypoxia has arisen as a result of the
recent settlements of mines and other activities at high
altitude (chronic intermittent hypoxia, CIH), where subjects
repeatedly ascend from sea level to 3800–4200m and work
in shifts, being exposed to hypoxia for longer periods than
in OSA conditions [3]. The large number of workers under
these circumstances, together with the known deleterious
cardiovascular effects reported in OSA patients [4], makes
it of utmost importance to study the mechanisms implicated
in CIH alterations. Since this condition is a relatively recent
phenomenon, studies are still limited and animal models are
valuable.We have used an experimental model of CIH, where
rats are exposed to hypobaric hypoxia in shifts resembling the
human situation [5]. We and others have found that under
these experimental conditions the rats develop pulmonary
hypertension, pulmonary vascular remodeling, and right
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ventricular hypertrophy [6, 7], which are milder compared
to rats chronically exposed to hypoxia [8].
Hypoxia-induced pulmonary hypertension and right
ventricular hypertrophy are related to pulmonary artery
vasoconstriction and vascular remodeling [9, 10], endothelial
nitric oxide (NO) being an important modulator of these
responses [11, 12]. Human and animal studies demonstrate
that OSA is associated with reduced NO availability, due
to a decreased production or destruction by an excess of
reactive oxygen species (ROS) [2] and pulmonary artery
vasoconstriction has been suggested to result from imbalance
between endothelial vasodilator factors and ROS [13]. NO-
ROS misbalance can also contribute to remodeling pro-
cess in the pulmonary vasculature, through modification of
cell migration, proliferation, dedifferentiation, and apoptosis
[14]. We have previously demonstrated that rats exposed
to long term CIH exhibit pulmonary artery remodeling
with characteristic features which differ from those found
under chronic exposure conditions [15, 16]. While there
are several studies in OSA conditions, to the best of our
knowledge, there are no data regarding the effect of hypoxia
maintained intermittently during days on NO/ROS balance
in the pulmonary vasculature.Therefore, we aimed to analyze
the possible alterations under this condition and to compare
them with those induced by continuous hypoxic exposure.
We have used a rat model mimicking the conditions of
subjects working in shifts or permanently living at high
altitude.
2. Materials and Methods
2.1. Animal Model. Three-month-old male Wistar rats were
used. The rats were exposed to 22 ± 2∘C, 12 h light/dark
cycle and were maintained in separate cages, with food
made available to them (20 g pellets/day per rat) and water
ad libitum. Standard veterinary care was used during all
of the experiments following institutional protocols for the
study of animals and the procedures used were approved by
the Institutional Research Ethics Committee of Universidad
Arturo Prat (Chile). The rats were randomly assigned to one
of the following groups:
normoxia control group (NX; 𝑛 = 10);
chronic intermittent hypoxia, 2 days under hypobaric
hypoxia and 2 days under normobaric normoxia for
46 days (CIH2x2; 𝑛 = 10);
chronic hypoxia, continuous hypobaric hypoxia for
46 days (CH; 𝑛 = 10).
Hypobaric hypoxia was simulated at Universidad Arturo
Prat facilities in a hypobaric chamber at 428 Torr, which is
equivalent to an altitude of 4600m (PO
2
= 89mmHg, PCO
2
= 0.15mmHg, temperature 22 ± 2∘C, and humidity 35 ± 5%).
Control (sea level) conditions were PO
2
= 159mmHg, PCO
2
= 0.29mmHg, temperature 22 ± 2∘C, and humidity 35 ± 5%.
The animal model for chronic intermittent hypoxia exposure
(CIH2x2) has been described previously [5, 8, 17].Thismodel
involves 2 days of hypoxia and 2 days of normoxia over a
period of 46 days. We maintained the rats for 46 days, since
previous data indicate that the hematological and cardiovas-
cular effects in the rat are maximal between 30 and 45 days
of exposure to hypoxia [5]. The 2x2 regimen was chosen in
order to mimic long term exposure to intermittent hypoxic
conditions as experienced by human subjects working in
shifts at high altitude, which is in the order of days (usually
7–14) [18], and including at least one full circadian cycle. The
control groupwas placed in the same room at sea level during
the 46-day period.
All the rats were weighted at day 1 and at day 46 using an
Acculab V-1200 electronic balance. At day 46 a blood sample
was taken from the tail and hematocrit was measured using
a microcentrifuge (Eppendorf AG, Hamburg, Germany).
Thereafter, the animals were euthanized with an overdose of
anesthesia (Ketamine, 8mg, i.p.) and the heart and the lungs
were removed in a block for further dissection.
The heart was cut down and the right ventricle was
detached from the heart, leaving in situ the septum portion
together with the left ventricle. Both ventricles were weighed
in an analytic balance (AcculabV-1200, Illinois, USA) and the
ratio between the right ventricle/left ventricle plus the septum
weight was used to measure the grade of right ventricular
hypertrophy. We did not use total heart weight or right
ventricular weight/body weight since we have previously
reported that exposure to hypoxia produces alterations in
body weight gain [5]. The removed lung was placed in
a Petri dish and pulmonary artery branches (4th order)
were dissected and stored for further experiments in saline
solution (0.9% NaCl).
2.2. Confocal Microscopy
2.2.1. Determination of NO Availability. Basal NO avail-
ability was determined by the fluorescent NO indicator
4,5-diaminofluorescein diacetate (DAF-2 DA, Sigma) as
described previously [19]. Briefly, 3mm length pulmonary
artery segments were stabilized in physiological salt solu-
tion (PSS; 115mmol/L NaCl, 4.6mmol/L KCl, 25mmol/L
NaHCO3, 1.2mmol/L KH2PO4, 1.2mmol/L, MgSO4, and
2.5mmol/L CaCl2), for 30min at 37
∘C, and oxygenated
with carbogen (95% O
2
and 5% CO
2
). Thereafter, they were
stained with oxygenated DAF-2 DA solution (10 𝜇mol/L) for
30min in the darkness at 37∘C, in a shaking water bath. This
experimental procedure in saturated oxygen ensures thatNO,
rather than O
2
, is the limiting factor in the reaction and the
fluorescence is directly proportional to NO [19]. Negative
controls for DAF-2 DA were incubated in 0.1mmol/L L-
NAME throughout the experimental period. The segments
were then washed 3 times for 1min each in PSS and fixed
in 4% (w/v) paraformaldehyde. The segments were cut in
rings with a blade and mounted on a slide equipped with
a small well made of spacers, filled with mounting medium
(Citifluor, Aname, Spain), and covered with a cover glass.
The arterial rings were visualized with a Leica TCS SP2
confocal system (Leica Microsystems, Wetzlar, Germany) at
Universidad Auto´noma de Madrid of Spain facilities using
the 488 nm/515 nm line. 1 𝜇m thick serial images (25𝜇m in
total) were captured with a 63x objective at zoom 2 in 3
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randomly chosen areas of the ring, at identical conditions of
brightness, contrast, and laser power for all of the experimen-
tal groups. MetaMorph image analysis software (Universal
Imaging Co., UK) was used for quantification of fluorescence
intensity. Briefly, the serial images were first reconstructed
in a confocal projection and fluorescence intensity was
quantified in several regions of the smooth muscle cells,
where the dye is trapped, avoiding the elastic lamella which is
also fluorescent in the same wavelength.
2.2.2. Determination of O
2
∙− Availability. Dihydroethidium
(DHE, Sigma) was used to determine basal O
2
∙−, as described
[19]. Briefly, 3mm long pulmonary arteries were stabilized in
PSS (30min at 37∘C). Thereafter, they were incubated with
3 𝜇mol/L DHE, washed 3 times for 1min each in PSS, and
fixed in 4% (w/v) paraformaldehyde. Negative controls for
DHE were incubated in 15 units/mL superoxide dismutase
(SOD) throughout the incubation period.The segments were
then washed 3 times for 1min each in PSS, fixed in 4% (w/v)
paraformaldehyde, cut in rings, and mounted as described
above. 1 𝜇m thick serial images (25 𝜇m in total) were captured
with a 63x objective at zoom 2 in 3 randomly chosen areas
of the ring, at identical conditions of brightness, contrast,
and laser power for all of the experimental groups with
the 488 nm/590–620 nm line of the microscope. MetaMorph
image analysis software (Universal Imaging Co., UK) was
used for quantification of fluorescence intensity, which was
located in the nuclei. The serial images were first recon-
structed in a confocal projection and fluorescence intensity
was quantified in several regions along the ring.
2.2.3. NADPH-Oxidase Detection by Immunohistochemistry.
To detect the presence of NADPH oxidase in the adventitial
layer, pulmonary arteries were first incubated with the pri-
mary antibody of the p22phox subunit of the enzyme (rabbit
polyclonal, Santa Cruz Biotechnology, USA) (60min, 1 : 200
in saline solution) at room temperature (RT) and thenwashed
with saline solution (30min, RT). Thereafter, the segments
were incubated with the secondary antibody-Alexa Fluor 647
goat anti-rabbit IgG (H + L) (Invitrogen, Madrid, Spain)
(60min, 1 : 200, RT in the darkness), followed by washing
for 30min, RT. Finally, they were incubated with the nuclear
dye 4󸀠,6-diamidino-2-phenylindole (DAPI; 1 : 500 from a
5mg/mL stock; 30min, RT in the darkness) andwashed twice
(30min, RT). The pulmonary arteries were longitudinally
sectioned and mounted with the adventitial side facing up,
as described above. The arteries were visualized with a
Leica TCS confocal system using the 405 nm excitation/410–
475 nm emission wavelength (DAPI) to locate the cells
and the 633 nm excitation/640–650 nm emission wavelength
(secondary antibody-Alexa 647) to detect the protein. 1 𝜇m
thick serial images of the adventitial layer (12 𝜇m in total)
were captured at both wavelengths with a 40x objective at
zoom 4 from 3 different regions. MetaMorph software was
used to count the total number of cells (DAPI positive) and
those stained with p22phox. Cell number (DAPI or p22phox
positive) was counted always in the same volume which was
calculated from the layer thickness (12𝜇m) and the image
area at ×40 zoom 4. We calculated the total number of
p22phox positive cells and the relative number of positive
cells (positive cells/total cells) in the mentioned volume.
2.3. Western Blot. Western blot was performed according
to the standard methods. Briefly, total pulmonary artery
tissues were frozen in liquid nitrogen and then homoge-
nized into homogenization buffer containing 50mM Tris-
HCl, 150mM NaCl, 100mM NaF, 1% Triton X-100, 1mM
dithiothreitol, 0.1mM phenyl methylsulfonyl fluoride, 1mM
leupeptin, 0.02M Hepes, 10−3M EDTA, 10−3M EGTA, and
20% glycerol, followed by centrifugation to 10000×g by
10min. Supernatant was removed and protein quantifica-
tion was carried out by Bradford assay. Equal amount of
protein (25 𝜇g) was resolved on 7.5–12% SDS-PAGE and
proteins were transferred to a PVDF membrane. The non-
specific binding sites on the membrane were blocked using
5% nonfat dry milk in TBS-T buffer (10mM Tris-HCl,
150mM NaCl, 0.05% tween 20, and pH 7.4) by 1 hour.
Membranes were incubated with primary antibody rabbit
polyclonal to PNK (3-nitrotyrosine) and p22phox and goat
polyclonal pNOS-3 (phosphorylated form of e-NOS; Santa
Cruz Biotechnology, USA) by overnight and washed three
times for 15, 10, 5min with TBS-T followed by incubation
with horseradish peroxidase-conjugated secondary antibody
(1 : 2000, Santa Cruz Biotechnology, USA) for 1 hour and
washed 3 times with TBS-T and once with TBS. Blots were
visualized using a West Pico Chemiluminescence System
(Pierce, USA) and then analyzed using Image J. Expression
levels of p22phox, PNK, and pNOS3 were normalized to 𝛽-
actin expression.
2.4. Statistical Analysis. The experimental data were entered
into a database and were analyzed using SPSS 17.0 statistical
package (SPSS, Inc., Chicago, Ill, USA). Mean, standard
deviation, and standard error were calculated for each
parameter. Normality was established using the Kolmogorov-
Smirnov test. Statistical analysis of the differences across all
testing conditions was established using analysis of variance
(ANOVA) of one factor and less significant difference post
hoc tests. All of the variables were normally distributed.
Statistical significance was established at a 𝑃 value < 0.05.
3. Results
3.1. Body Weight Gain, Hematocrit, and Right Ventricular
Hypertrophy. Body weight at day 1 was not statistically
different between experimental groups (NX: 247.8 ± 16.6 gr,
CIH2x2: 246.9± 11.2 gr, and CH: 251.5± 17.2 gr). While NX
rats gained weight over the 46-day period (final body weight
NX = 330 ± 13.5 g), there was a gradual weight loss in both
hypoxic groups (final bodyweight CIH2x2 = 206± 8.03 g; CH
= 169 ± 3.6 g), being significantly smaller compared to NX
(𝑃 < 0.001). Hematocrit at the end of experimental period
was significantly higher in CH (66 ± 1.1%) and in CIH2x2
(58 ± 1.8%), compared to NX rats (51 ± 1.0%) (𝑃 < 0.01).
CIH2x2 hematocrit was significantly smaller compared to
CH (𝑃 < 0.01). Right ventricular weight/total heart weight
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Figure 1: DAF-2 DA intensity levels in pulmonary arteries from rats exposed to normoxia (NX, 𝑛 = 10), intermittent hypoxia (CIH2x2,
𝑛 = 10), or chronic hypoxia (CH, 𝑛 = 10). (a) Representative examples of projections obtained from confocal microscopy images (×40 zoom
2). (b) Quantitative analysis; 𝑛 represents the number of animals; ∗𝑃 < 0.05 compared to NX; †𝑃 < 0.05 compared to CIH2x2.
was smaller in NX (NX = 0.23 ± 0.02; 𝑃 < 0.01) compared
to CIH2x2 rats (0.34 ± 0.02) and CH group (0.40 ± 0.02),
which was also significantly larger compared to intermittent
exposure group (𝑃 < 0.05).
3.2. NO Availability. The fluorescence emitted by DAF-2
DA was located in the cytoplasm of smooth muscle cells.
Pulmonary arteries from NX group exhibited a significantly
higher DAF-2 DA emitted fluorescence compared to both
hypoxic groups, suggesting a larger basal NO availability [19].
Fluorescence was significantly lower in CH rats compared to
CIH2x2 (Figure 1).
3.3. O
2
∙− Availability. DHE fluorescence was located in the
cell nuclei. NX rats showed a smaller level of fluorescence
intensity compared to both hypoxic groups, being higher in
CH compared to CIH2x2 (Figure 2).
3.4. Phosphorylated eNOS, p22phox, and 3-Nitrotyrosine
Expression. Expression of the phosphorylated form of eNOS
was significantly reduced in CH compared to NX. The
expression levels in CIH2x2 were not statistically different
from NX (Figure 3(a)).
p22phox expressionwas scarcely detectable in pulmonary
arteries from NX but was largely increased in both hypoxic
rats, without differences between CH and CIH2x2 groups
(Figure 3(b)).
3-Nitrotyrosine expression, a marker of nitrosative dam-
age, was significantly elevated in pulmonary arteries from
hypoxic rats compared toNX, being significantly larger inCH
compared to CIH2x2 (Figure 3(c)).
3.5. p22phox Location in the Adventitia. The total number of
adventitial cells, quantified by the nuclear dye DAPI in a fixed
volume, was significantly higher in pulmonary arteries from
BioMed Research International 5
NX CIH2x2 CH
50𝜇m
(a)
†
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
NX
CIH2x2
CH
In
te
ns
ity
 (r
el
at
iv
e u
ni
ts)
∗
∗
(b)
Figure 2: DHE intensity levels in pulmonary arteries from rats exposed to normoxia (NX, 𝑛 = 10), intermittent hypoxia (CIH2x2, 𝑛 = 10),
or chronic hypoxia (CH, 𝑛 = 10). (a) Representative examples of projections obtained from confocal microscopy images (×40 zoom 2). (b)
Quantitative analysis; 𝑛 represents the number of animals; ∗𝑃 < 0.05 compared to NX; †𝑃 < 0.05 compared to CIH2x2.
both hypoxic rats (CIH2x2 = 144.7 ± 13.2; CH = 157.1 ± 9.7)
compared to control (NX = 74.9 ± 2.6, 𝑃 < 0.001).
P22phox staining was observed in the three experimental
groups and was located around some of the adventitial cells.
Pulmonary arteries from hypoxic rats exhibited a larger level
of staining compared to NX (Figure 4(a)). Both total and
relative numbers of p22phox positive cells were significantly
larger in the adventitial layer of hypoxic rats compared toNX,
with no statistical difference between CIH2x2 and CH rats
(Figure 4(b)).
4. Discussion
The main findings of the current study are that exposure to
chronic intermittent hypoxia reduces NO availability in the
pulmonary vasculature. This decrease is likely due to NO
destruction by O
2
∙−, generated by NADPH-oxidase, while
eNOS is not altered. On the other hand, in continuous
exposure to hypoxia, NO availability is further reduced,
through the combination of diminished NO synthesis and
increased destruction. In consequence, chronic hypoxia pro-
duces larger nitrosative damage compared to intermittent
exposure, which likely contributes to the higher impact on
pulmonary artery remodeling and right ventricular hypertro-
phy (Figure 5 summarizes these results).
The present data confirmed that hypoxia induced weight
loss, right ventricular hypertrophy, and hematocrit increase,
as previously described by us [8] and others [6, 7]. We
have also described remodeling of the pulmonary vasculature
[15, 16], these alterations being less severe under intermittent
exposure. We aimed to assess if the above mentioned cardio-
vascular alterations are linked toNO/ROSmisbalance. To the
best of our knowledge, there is virtually no information in
long term intermittent hypoxia conditions, the majority of
evidence coming from OSA studies [20], where low oxygen
levels are maintained for very brief periods.
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Figure 3: Western blot analysis of: (a) phosphorylated eNOS, (b) p22phox, and (c) 3-nitrotyrosine from pulmonary arteries of rats exposed
to normoxia (NX, 𝑛 = 9), intermittent hypoxia (CIH2x2, 𝑛 = 10), or chronic hypoxia (CH, 𝑛 = 10). (d) Representative examples. 𝑛 represents
the number of animals; ∗𝑃 < 0.05 compared to NX; †𝑃 < 0.05 compared to CIH2x2.
We focused on NO, a key factor for pulmonary artery
resistance [12], since diminished NO availability likely affects
both pulmonary artery structure and function. Furthermore,
studies on rodents have revealed that intermittent exposure
to hypoxia is associated with NO reduction in the systemic
and cerebral vasculature [21, 22]. Decreased NO availability
in the pulmonary vasculature can be the result of a reduced
production by eNOS and/or an increased destruction by
ROS, particularly O
2
∙−, which has been implicated in hypoxic
pulmonary vasoconstriction [13, 23–25]. To determine NO
availability, we used DAF-2 DA, a fluorescent indicator
directly proportional to the amount of NO [26, 27]. Using
confocal microscopy and image analysis software, we have
previously demonstrated that this method is sufficiently
sensitive for the quantification of basal NO in resistance and
conduit arteries [19, 28, 29]. Continuous hypoxia induced a
larger reduction of NO availability, compared to intermittent
exposure.This can be explained by a reducedNOproduction,
as suggested by the decreased expression of phosphorylated
eNOS—the active form of the enzyme—found in chronic
hypoxia only.The lack of effect of intermittent exposure could
be explained by the functional “on-off” (hypoxia-normoxia)
switch [30] which is not able to induce downregulation of the
NO biosynthetic machinery.
Reduced NO availability in hypoxic conditions seems
also to be related to NO destruction by O
2
∙−. This is
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(b) p22phox positive cells
Figure 4: Immunohistochemical detection of p22phox positive cells in the adventitia of pulmonary arteries from rats exposed to normoxia
(NX, 𝑛 = 10), intermittent hypoxia (CIH2x2, 𝑛 = 10), or chronic hypoxia (CH, 𝑛 = 10). (a) Representative examples of projections obtained
from confocal microscopy images (×40 zoom 4). (b) Quantitative analysis; 𝑛 represents the number of animals; ∗𝑃 < 0.05 compared to NX.
suggested by the increased superoxide anion production
found in CIH2x2 and CH pulmonary arteries, similarly
to data described in an OSA rat model [31]. Superoxide
anion levels were even higher in continuous compared to
intermittent hypoxia, suggesting that continuous exposure
further stimulates the enzymatic systems responsible for ROS
synthesis. In the vascular wall, several enzymes produceO
2
∙−,
NADPH oxidase being the main system in the pulmonary
vasculature [13, 32]. We found a remarkable expression
of this enzyme—confirmed by immunohistochemistry—in
both CH and CIH2x2, while it was very low in normoxic rats.
The important role of this enzyme in intermittent hypoxia has
been previously demonstrated in NADPH-oxidase knock-
out mice exposed to OSA [33]. Our data show that O
2
∙−
levels were larger in continuous compared to intermittent
hypoxia, despite the similar p22phox expression in both
groups. This could be explained by O
2
∙− production by
xanthine oxidase, as suggested in OSA patients and animal
models [34, 35]. Since it has been reported that, under
hypoxic conditions, O
2
∙− generated by xanthine oxidase is
very small [36], alternatively, O
2
∙− can be produced by
“uncoupled” dysfunctional eNOS, which can be induced
by peroxynitrite [37]. We did not measure peroxynitrite
directly but quantified 3-nitrotyrosine, which is currently
accepted as evidence of peroxynitrite generation. The larger
content of 3-nitrotyrosine found in CH suggests that eNOS
uncoupling can contribute to larger O
2
∙− production found
in continuous hypoxic conditions compared to intermittent
conditions, despite the similar NADPH oxidase expression in
both groups.
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Figure 5: Schematic diagram showing the main results and the proposed mechanism implicated in the NO/O
2
∙− misbalance induced by
chronic and intermittent hypoxia.
Oxidative-nitrosative stress is associated with vascular
remodeling in hypoxia-induced pulmonary hypertension
[38].We have previously found several signs of remodeling in
pulmonary arteries fromCH and CIH2x2 rats, including wall
hypertrophy due to increased smooth muscle and adventitial
cells [15, 16]. Adventitial NADPH oxidase has been described
to be involved in pulmonary artery adventitial fibroblasts
proliferation [39, 40] and seems to be a primary site of
superoxide anion production in the vessel wall [41–43].
We found that chronic or intermittent hypoxia substantially
increased adventitial cell number together with a larger
percentage of NADPH-positive cells. Moreover, we [44] and
others [43] have previously demonstrated that adventitia is a
key layer regarding NO inactivation by ROS. Since NO is an
antiproliferative agent, we suggest that an imbalance between
NO/O
2
∙− can be linked to the vascular remodeling process
under continuous or intermittent hypoxic exposure.
It was beyond the scope of this study to investigate
the mechanisms implicated in hypoxia-induced NO/ROS
disbalance. However, we can speculate on the possible role
of inflammation. Alveolar hypoxia produces widespread
systemic inflammation [45] and it also promotes the
development of a pulmonary artery chronic inflammatory
microenvironment [46]. We also have evidence of infiltrated
macrophages in pulmonary arteries from CH and CIH2x2
(unpublished results), suggesting that local inflammation in
the vascularwallmight contribute to theNO/ROSdisbalance.
In support of this hypothesis, there is evidence that tumor
necrosis factor-𝛼 can reduce eNOS expression and activity in
pulmonary arteries [47]. Moreover, inflammation associated
with macrophage infiltration can also contribute to ROS gen-
eration through stimulation of NADPH oxidase expression,
as previously found in the carotid body under intermittent
hypoxic conditions [48].
In conclusion, the present study suggests that hypobaric
hypoxia under intermittent conditions reduces NO availabil-
ity due to destruction by superoxide anion, without affecting
NO synthesis, while continuous exposure is associated with
both increased degradation and reducedNOproduction.The
oxidative-nitrosative stress induced by long term intermittent
hypoxia might participate in the observed cardiovascular
structural alterations but represents a milder form of damage
compared to continuous exposure. These data suggest that
the alterations in oxidative status of humans chronically or
intermittently exposed to high altitude need to be evaluated,
in order to improve the associated cardiovascular alterations.
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